跳至主要内容
临床试验/NCT00475605
NCT00475605终止不适用

APPLES: A Prospective Pediatric Longitudinal Evaluation to Assess the Long-Term Safety of Tacrolimus Ointment for the Treatment of Atopic Dermatitis

LEO Pharma301 个研究点 分布在 1 个国家目标入组 8,071 人开始时间: 2005年5月25日最近更新:
适应症

试验速览

阶段
不适用
状态
终止
发起方
LEO Pharma
入组人数
8,071
试验地点
301
主要终点
Occurrence of systemic or cutaneous malignancy

研究概览

简要总结

This is an observational study to assess the long-term safety of Protopic® Ointment for the treatment of atopic dermatitis. Patients whose ages are/were < 16 years at the time of first tacrolimus ointment exposure are eligible to participate. No drug is distributed during this observational trial.

详细描述

Data will be collected at enrollment and every 6 months thereafter either by interview, Internet, or physician office visit. Each subject will be followed for 10 years in this study.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
— 至 16 Years(Child)
性别
All
接受健康志愿者

入选标准

  • Subjects who first used Protopic® 0.03% or 0.1% before they were sixteen years of age and were treated for at least 6 weeks for the treatment of Atopic dermatitis may enroll into the study.

排除标准

  • 未提供

结局指标

主要结局

Occurrence of systemic or cutaneous malignancy

时间窗: 10 years

Standardised Incidence Ratio (versus population cancer rates)

次要结局

未报告次要终点

研究者

发起方
LEO Pharma
申办方类型
Industry
责任方
Sponsor

研究点 (301)

Loading locations...

相似试验

A Pediatric Longitudinal Evaluation to Assess the... | 临床试验